Health
Longer gap in Pfizer-BioNTech COVID vaccines boosts antibody levels: Study – India TV News
A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune…
A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found. The study, led by the University of Oxford, in collaboration with the Universities of Birmingham,…
Continue Reading
-
General8 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
Business24 hours agoWhat Warren Buffett’s farewell letter means for Berkshire Hathaway investors
-
General24 hours agoEnvironment Bill passes Senate as Greens cut deal with Labor
-
General23 hours agoCalls for states to change alcohol laws ahead of women’s ministers meeting